Latest News

Deductibles a threat to more imaging after abnormal mammogram


 

AT RSNA 2022

Education efforts may help

Brian N. Dontchos, MD, with the University of Washington in Seattle, who was not part of the study, views the data another way. He told this news organization, “It is encouraging from the study that the majority of women would pursue additional imaging after an abnormal screening mammogram despite incurring more cost.”

He said that since direct patient education “has been shown to be effective in improving patient participation in screening programs, it is possible that, with more education of patients and providers, that advocacy could influence payers to support downstream imaging and biopsies that result from screening programs.”

Dr. Ngo, Dr. Berg, and Dr. Dontchos report no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Late detection and worse outcomes in invasive lobular vs ductal carcinomas of the breast
MDedge Hematology and Oncology
Invasive BC: Severe chemotherapy-induced peripheral neuropathy with nab-paclitaxel
MDedge Hematology and Oncology
Proton-pump-inhibitors can be used with ribociclib in metastatic BC
MDedge Hematology and Oncology
Elevated breast cancer risk in thyroid cancer survivors partly due to I-131 treatment
MDedge Hematology and Oncology
Increased risk for second primary lung cancer in breast cancer patients
MDedge Hematology and Oncology
ER+ BC: Elderly patients can opt for endocrine monotherapy and avoid local invasive treatment
MDedge Hematology and Oncology
HER2+ BC: Crofelemer fails to prevent any grade chemotherapy-induced diarrhea in phase 2
MDedge Hematology and Oncology
Commentary: New treatments and management in breast cancer, December 2022
MDedge Hematology and Oncology
Whole breast radiation for breast cancer shown to be safe and effective
MDedge Hematology and Oncology
Managing trastuzumab deruxtecan adverse events in the real world
MDedge Hematology and Oncology